Cargando…

Impact of chromosomal instability on colorectal cancer progression and outcome

BACKGROUND: It remains presently unclear whether disease progression in colorectal carcinoma (CRC), from early, to invasive and metastatic forms, is associated to a gradual increase in genetic instability and to a scheme of sequentially occurring Copy Number Alterations (CNAs). METHODS: In this work...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsetti, Béatrice, Selves, Janick, Bascoul-Mollevi, Caroline, Lasorsa, Laurence, Gordien, Karine, Bibeau, Frédéric, Massemin, Blandine, Paraf, François, Soubeyran, Isabelle, Hostein, Isabelle, Dapremont, Valérie, Guimbaud, Rosine, Cazaux, Christophe, Longy, Michel, Theillet, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233623/ https://www.ncbi.nlm.nih.gov/pubmed/24559140 http://dx.doi.org/10.1186/1471-2407-14-121

Ejemplares similares

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse
por: du Manoir, Stanislas, et al.
Publicado: (2013)

Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants
por: Selves, Janick, et al.
Publicado: (2023)

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016)

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q
por: Orsetti, B, et al.
Publicado: (2006)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
por: Labrousse, Guillaume, et al.
Publicado: (2023)

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis
por: Bonnet, Françoise, et al.
Publicado: (2012)

Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study
por: Kirzin, Sylvain, et al.
Publicado: (2014)

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2018)

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2017)

BAGE Hypomethylation Is an Early Event in Colon Transformation and Is Frequent in Histologically Advanced Adenomas
por: Lana, Erica, et al.
Publicado: (2009)

Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization
por: Ho-Pun-Cheung, Alexandre, et al.
Publicado: (2009)

Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
por: Pérot, Gaëlle, et al.
Publicado: (2014)

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial
por: Assenat, Eric, et al.
Publicado: (2015)

Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas
por: Soubeyran, P, et al.
Publicado: (1999)

Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure
por: Colombo, Pierre-Emmanuel, et al.
Publicado: (2015)

TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion
por: Chevalier, Clément, et al.
Publicado: (2016)

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes
por: Jaffrelot, Marion, et al.
Publicado: (2021)

Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
por: Nuemi, Gillles, et al.
Publicado: (2015)

Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol
por: Modesto, Anouchka, et al.
Publicado: (2023)

A refined molecular taxonomy of breast cancer
por: Guedj, M, et al.
Publicado: (2012)

High-throughput detection of clinically targetable alterations using next-generation sequencing
por: Vendrell, Julie A., et al.
Publicado: (2017)

Clinical impact of extensive molecular profiling in advanced cancer patients
por: Cousin, Sophie, et al.
Publicado: (2017)

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
por: Selves, Janick, et al.
Publicado: (2018)

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications
por: Nugoli, Mélanie, et al.
Publicado: (2003)

Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study
por: Anota, Amélie, et al.
Publicado: (2014)

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
por: Szablewski, Vanessa, et al.
Publicado: (2013)

Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer
por: Bournet, Barbara, et al.
Publicado: (2011)

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
por: Ladjemi, Maha Z, et al.
Publicado: (2011)

A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors
por: Palassin, Pascale, et al.
Publicado: (2021)

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers
por: Lamy, Pierre-Jean, et al.
Publicado: (2011)

Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
por: Delpu, Yannick, et al.
Publicado: (2011)

Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases
por: Del Rio, Maguy, et al.
Publicado: (2013)

A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study
por: Chanrion, Maïa, et al.
Publicado: (2007)

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
por: Anota, Amélie, et al.
Publicado: (2013)

Network Analysis Shows Asymmetrical Flows within a Bird Metapopulation
por: Rojas, Emilio R., et al.
Publicado: (2016)

Human Adipose‐Derived Stem Cells Expanded Under Ambient Oxygen Concentration Accumulate Oxidative DNA Lesions and Experience Procarcinogenic DNA Replication Stress
por: Bétous, Rémy, et al.
Publicado: (2016)

BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib
por: Velazquez, Carolina, et al.
Publicado: (2023)

Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization: Our experience and literature review
por: Maulat, Charlotte, et al.
Publicado: (2017)

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program
por: Aparicio, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ee6fc2loab3o6vjqrqv9kl72gn